|
他汀类药物对慢性心力衰竭治疗作用的新认识 |
|
KarasRH. Statin use enhances coronary collaterals [J].Am Heart J, 2003, 146(7): 876-881. [5] LandmesserU, Bahlmann F, MullerM,et al. Simvastatin versus ezetimibe: pleiotropic and lipidlowering effects on endothelial func- tion in humans [J].Circulation, 2005, 111(18): 2356-2363. [6] DechendR, FiebelerA, Park JK,etal.Amelioration ofangiotension II-induced injury by a 3-hydroxy-3-methyglutaryl coenzyme a reductase inhibitor [J].Circulation, 2001, 104(5): 576-581. [7] 张冬颖.他汀类药物改善心室重塑的研究进展[J].重庆医学, 2004, 33(10): 1581-1583. [8] Nolan J, Batin PD,AanrewsR,etal. Prospective study ofheart rate variability andmortality in chronic heart failure: results of theUnit- ed Kingdom heart failure evaluation and assessment of risk trial (UK-heart)[J].Circulation, 1998, 98(15): 1510-1516. [9] PliquettRU, Cornish KG, Peuler JD,et al. Simvastatin normalizes autonomic neural control in experimentalheart failure[J].Circula- tion, 2003, 107(19): 2493-2498. [10] Keith M, Geranmayegan A, Sole MJ,et al. Increased oxidative stress in patientswith congestive heart failure [J]. JAm CollCar- dio,l 1998, 31(6): 1352-1356. [11] Bandoh T, Sato EF,Mitan IH,etal.Antioxidative potential of&n上一页 [1] [2] [3] [4] [5] [6] 下一页 上一个医学论文: 不同治疗方法对高龄血液透析患者低血压的干预效果 下一个医学论文: 钙网蛋白抗肿瘤免疫治疗的新靶点
|
|
|